The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Radiology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-015-4082-8PMID 26560727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.

  2015cited by this paper
• The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma.

  2015influential reference
• A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma

  2015cited by this paper
• mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response

  2015cited by this paper
• The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

  2015cited by this paper
• CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

  2015cited by this paper
• Nivolumab in previously untreated melanoma without BRAF mutation.

  2015cited by this paper
• First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

  2014cited by this paper
• Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.

  2014cited by this paper
• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

  2014cited by this paper
• ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.

  2014cited by this paper
• ‘Master protocol’ aims to revamp cancer trials

  2013cited by this paper
• Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma

  2013cited by this paper
• Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.

  2013cited by this paper
• Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

  2013cited by this paper
• External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.

  2013cited by this paper
• Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

  2012cited by this paper
• Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.

  2012cited by this paper
• Trial watch: Phase II failures: 2008–2010

  2011cited by this paper
• Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

  2011cited by this paper
• Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

  2009cited by this paper
• Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.

  2009influential reference
• Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

  2008cited by this paper
• Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.

  2007cited by this paper
• Decoding global gene expression programs in liver cancer by noninvasive imaging

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Understanding interobserver agreement: the kappa statistic.

  2005cited by this paper
• Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.

  2005cited by this paper
• GoMiner: a resource for biological interpretation of genomic and proteomic data

  2003cited by this paper
• A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship

  1974cited by this paper

• A radiogenomics biomarker based on tumor angiogenesis for non-invasive prognosis of clear cell renal cell carcinoma.

  2025cites this paper
• From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non‐Invasive Precision Medicine in Cancer Patients

  2024cites this paper
• Radiogenomics: a key component of precision cancer medicine

  2023cites this paper
• Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study

  2023cites this paper
• Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects

  2023cites this paper
• Construction of a radiogenomic association map of pancreatic ductal adenocarcinoma

  2023cites this paper
• Meta-research: How many diagnostic or prognostic models published in radiological journals are evaluated externally?

  2023cites this paper
• Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature

  2023cites this paper
• Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions

  2022influential citation
• The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics—Definition, Current Advances, and Future Directions

  2022cites this paper
• Background, applications and challenges of radiogenomics in genitourinary tumor.

  2021cites this paper
• Tissue clearing techniques for three‐dimensional optical imaging of intact human prostate and correlations with multi‐parametric MRI

  2021cites this paper
• radiogenomics in genitourinary tumor

  2021cites this paper
• Clinical implications of intratumor heterogeneity: challenges and opportunities

  2020cites this paper
• Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies.

  2020cites this paper
• Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation

  2020cites this paper
• Radiogenomics of Oncology

  2019cites this paper
• Radiogenomics in renal cell carcinoma

  2019cites this paper
• Use of Precision Imaging in the Evaluation of Pancreas Cancer.

  2019cites this paper
• MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.

  2019cites this paper
• Receptor-based Surrogate Subtypes and Discrepancies with Breast Cancer Intrinsic Subtypes: Implications for Image Biomarker Development.

  2018cites this paper
• Radiogenomics and IR.

  2018cites this paper
• Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats

  2018influential citation
• Lung Cancer Radiogenomics: The Increasing Value of Imaging in Personalized Management of Lung Cancer Patients

  2018cites this paper
• Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis

  2018influential citation
• Imaging Advances in the Management of Kidney Cancer.

  2018cites this paper
• Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers.

  2017cites this paper
• Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study.

  2017cites this paper
• Sonoelastomics for Breast Tumor Classification: A Radiomics Approach with Clustering-Based Feature Selection on Sonoelastography.

  2017cites this paper
• Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.

  2017cites this paper
• Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

  2017cites this paper
• Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma Patients

  2017cites this paper
• BJRD151030 1..17

  2016cites this paper
• Imaging genomics in cancer research: limitations and promises.

  2016cites this paper
• Demonstrates associations between 18 F-Fluoro-2-Deoxyglucose PeT , Prognosis , and epithelial-Mesenchymal Transition in non – small cell lung cancer 1

  2016cites this paper
• Update on Radiogenomics of Clear Cell Renal Cell Carcinoma.

  2016cites this paper
• Novel imaging in renal cell carcinoma

  2016cites this paper